The Involvement of Breast Cancer Patients During Oncological Consultations

Breast Cancer Clinical Trial

— INCA  

Official title:

The Involvement of Breast Cancer Patients During Oncological Consultations. A Multi-centre Randomized Controlled Trial. The Study Protocol

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01510964
• Other study ID #: INCA (CE.Prot. 1719)
• Status: Completed
• Phase: N/A
• First received: December 22, 2011
• Last updated: August 9, 2013
• Start date: June 2011
• Est. completion date: May 2013

Study information

• Verified date: December 2011
• Source: Azienda Ospedaliera Universitaria Integrata Verona
• Contact: n/a
• Is FDA regulated: No
• Health authority: Scientific Committee: Prof. Christa Zimmermann, Prof. Lidia Del Piccolo
• Study type: Interventional

Clinical Trial Summary

The main aim of the study is to assess if a pre consultation intervention facilitates greater participation of patients (and accompanying key persons when present) in the consultation process by determining an increase in questioning and/or in the number of different illness related issues (e.g. diagnosis, treatment, prognosis) being discussed with the oncologist.

Other aims are to assess the effect of the intervention on the oncologist's level of patient involvement, on patient satisfaction and coping and to explore the role of key persons accompanying the patient.

The investigators expect that patients who have the opportunity to rehearse their informative needs before the consultation will ask a greater number of questions which in turn will determine their greater involvement by the physician and a greater number of satisfied needs. The investigators expect also that the straightforward use of a list of printed questions of potential relevance for cancer patients and their companions at an early stage of illness, by modifying the process of information exchange, increases their participation and satisfaction with the consultation, with potential benefits for treatment adherence and consequently treatment efficacy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: May 2013
• Est. primary completion date: May 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• all consecutive patients

• age between 18 and 75 years

• attending the Oncology Out-patient Clinics of the participating centres

• recent diagnosis of breast cancer at an early stage

Exclusion Criteria:

• presence of metastasis or relapse

• severe mental deterioration

• comprehension difficulties of the Italian language.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Intervention

Behavioral:
• prompt-sheet
Prompt sheet is a form on which to write the reply to the following request: "Please indicate the arguments which you want to discuss today with your oncologist" and a written list of possible questions the patient (companion) would like to ask to the oncology.
• control group
Patients and companions of the control group receive a form on which to write their reply to the following request: "Please indicate the arguments which you want to discuss today with your oncologist"

Locations

Country	Name	City	State
Italy	Azienda Ospedaliera Universitaria Integrata	Verona

Sponsors (1)

Lead Sponsor	Collaborator
Azienda Ospedaliera Universitaria Integrata Verona

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of question during the consultation	The intervention prompt-sheet aims to increase the number of question by giving the opportunity to patients and companions to reflect on their informative needs on the basis of a wide range of possible questions from which to choose those perceived as most relevant in view of the subsequent consultation. Question asking is considered an index for patient participation during the consultation. The total number of patient questions during the consultation regarding diagnosis, prognosis, treatment and other issues is the primary outcome measure.	1 hour after the intervention (question prompt-sheet)	No
Secondary	The number of informative needs not met during the consultation.	This measure is derived by comparing the number of questions indicated by patients and their companion before the consultation with those actually raised during the consultation	1 hour after the intervention (question prompt-sheet)	No
Secondary	Ability to cope with the illness	the Patient Enablement Instrument (PEI) is a questionnaire of six items on a Likert scale from 0 (same or less) to 2 (much better, much more), administered after the consultation.	2 hours after the intervention (question prompt-sheet)	No
Secondary	Patient involvement (SDM-Q and OPTION)	The SDM-Q is a self administered questionnaire of 9 items on a Likert scale from 1 to 6 and assesses patients' perception of the decisional process and their level of involvement during the consultation. The OPTION Scale is composed of 12 items of operational definitions of different patient involving skills, rated on a Likert scale from 0 to 4. The scale is applied by trained raters to the audio-recording of the consultation	2 hours after the intervention (question prompt-sheet)	No
Secondary	Satisfaction with decisions (SWD).	Satisfaction with Decision Scale (SWD) is a questionnaireof 6 items on a Likert scale from 0 (completely disagree) to 5 (agree completely), administered after the consultation.	2 hours after the intervention (question prompt-sheet)	No
Secondary	Recalling and understanding of information	The Recall Questionnaire consists of six questions which ask the patient's to recall the received information on treatment decisions and pathology. We added three other questions, rated on a 0 (no at al) to 5 (very much) likert scale asking whether the patient succeeded in their purpose of question asking, whether the oncologist answered the questions properly and how much more information she would have needed.	2 hours after the intervention (question prompt-sheet)	No
Secondary	Overall consultation atmosphere (VR-COPE, RIAS, AIMIT on the audio-recorded consultation)	VRCOPE assesses the content, the process and relational aspects of patient-centred communication during medical consultations on the basis of a multidimensional evaluation and comprises nine items. RIAS is a coding system of medical consultations, composed by 40 categories describing interactions between doctors and patients. AIMIT is a coding system to assess in the therapeutic dialogue the activity of interpersonal motivational systems that guide the verbal and non verbal behaviors during interactions.	1 hour after the intervention (question prompt-sheet)	No
Secondary	Perceived Patient-doctor relationship (PDRQ-9 and DDPRQ-10)	PDRQ-9 is a self-administered (after the consultation) questionnaire of 9 items on a Likert scale from 1 to 5, to measure the relationship between the doctor and the patient, from a patient point of view.The DDPRQ-10 is a self-report instrument of 10 items on a Likert scale from 1 to 6, completed by physicians after an encounter with a patient.	2 hours after the intervention (question prompt-sheet)	No
Secondary	Perceived role preference of the patient (CPS)	CPS (Oncologist version) assesses how the oncologist perceives the role that patient might prefer regarding the decision making process.	2 hours after the intervention (question prompt-sheet)	No